IBM has announced that Jupiter Medical Center will implement Watson for Oncology’s platform to provide physician insights to deliver personalized, evidence-based cancer treatment. The announcement marks Jupiter as the first U.S. community hospital to adopt Watson for Oncology, which is scheduled to go-live at the beginning of March.
Trained by Memorial Sloan Kettering (MSK), Watson for Oncology provides information to oncologists to help them deliver evidence-based treatment options by analyzing massive volumes of medical literature to identify individualized treatment options and scaling access to oncology expertise. The platform draws from more than 300 medical journals, more than 200 textbooks, and nearly 15 million pages of text to provide insights about different treatment options and also provides oncologists with information regarding drug options and administration instructions. Watson also ranks the evidence-based treatment options, linking to peer reviewed studies and clinical guidelines. Its machine-learning capability means it continuously learns, gaining in value and knowledge over time.
In the U.S., there will be an estimated 1.7M new cancer cases this year, with 125,000 in Florida alone. As healthcare providers and systems seek to enable data-driven, evidence-based cancer care, an explosion of medical information has created both challenges and opportunities to improve quality care. Currently, approximately 50,000 oncology research papers are published annually
IBM and Memorial Sloan Kettering (MSK) have been accelerating Watson for Oncology’s training; Watson for Oncology is now available to assist clinicians in developing treatment plans for breast, lung, colorectal, cervical, ovarian and gastric cancers. IBM and MSK plan to train Watson on at least 9 additional cancer types this year, covering nearly 80 percent of the worldwide incidence of cancer.
“We were impressed by Watson’s analytical ability to help provide relevant treatment options for patients to allow physicians to personalize patient care in an unparalleled way,” said Abraham Schwarzberg, MD, Chief of Oncology at Jupiter Medical Center. “Harnessing the power of Watson will help our oncology multidisciplinary team identify individual treatments. As one of the first in the country to implement this incredible tool, Jupiter Medical Center continues to be a regional leader in integrating technology to provide cutting-edge clinical care.”
